Implication of nanoparticles/microparticles in mucosal vaccine delivery (Q36837152)

16 August 2017

1 reference

title

Implication of nanoparticles/microparticles in mucosal vaccine delivery (English)

1 reference

16 August 2017

0 references

Suresh P Vyas

1 reference

16 August 2017

Prem N Gupta

series ordinal

1 reference

16 August 2017

publication date

1 June 2007

1 reference

Expert Review of Vaccines

16 August 2017

published in

1 reference

16 August 2017

1 reference

16 August 2017

1 reference

16 August 2017

page(s)

401-418

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

16 August 2017

1 reference

Mucosal vaccines: the promise and the challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Mucosal immunity and tolerance: relevance to vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Vaccination strategies for mucosal immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Immunologic uniqueness of the genital tract: challenge for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Mucosal HIV vaccines: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Mucosal immunity and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Mucosal delivery of vaccine antigens and its advantages in pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

NFAT proteins: key regulators of T-cell development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Immunomodulators and delivery systems for vaccination by mucosal routes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Recent advances in mucosal vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Experience with registered mucosal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Polymeric carriers for oral uptake of microparticulates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Lectin anchored stabilized biodegradable nanoparticles for oral immunization 1. Development and in vitro evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Formulation, characterization and release studies of alginate microspheres encapsulated with tetanus toxoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

The effect of physical barriers and properties on the oral absorption of particulates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

21 January 2018

Mucin-Type Glycoproteins

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Cell culture modeling of specialized tissue: identification of genes expressed specifically by follicle-associated epithelium of Peyer's patch by expression profiling of Caco-2/Raji co-cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Peptidoglycan recognition protein expression in mouse Peyer's Patch follicle associated epithelium suggests functional specialization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Mannosylated niosomes as adjuvant-carrier system for oral mucosal immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

The invasin protein of Yersinia enterocolitica: internalization of invasin-bearing bacteria by eukaryotic cells is associated with reorganization of the cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Lectin-mediated mucosal delivery of drugs and microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

The design of vaccines against Helicobacter pylori and their development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(D,L-lactide-co-glycolide) microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Intranasal vaccines: forthcoming challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Immunological mechanisms of sublingual immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Immune mechanisms of allergen-specific sublingual immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Biodegradation and biocompatibility of PLA and PLGA microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

A comparative biocompatibility study of microspheres based on crosslinked dextran or poly(lactic-co-glycolic)acid after subcutaneous injection in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Chitosan nanoparticles encapsulated vesicular systems for oral immunization: preparation, in-vitro and in-vivo characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Mucosal antibody response induced with a nasal virosome-based influenza vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Targeting polymerised liposome vaccine carriers to intestinal M cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Induction of protective and mucosal immunity against diphtheria by a immune stimulating complex (ISCOMS) based vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Plant-made vaccines: biotechnology and immunology in animal health

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Immunogenicity in humans of an edible vaccine for hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Microbial-gut interactions in health and disease. Progress in enteric vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Immunization without needles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Therapeutic vaccines: realities of today and hopes for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Utilizing bacterial mechanisms of epithelial cell entry: invasin-induced oral uptake of latex nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.3.401

21 January 2018

Identifiers

DOI

10.1586/14760584.6.3.401

1 reference

16 August 2017

1 reference